Shackelford D A, Trowbridge I S
J Biol Chem. 1986 Jun 25;261(18):8334-41.
The interleukin-2 (IL-2) receptor, the leukocyte-specific membrane glycoprotein, T200, and the class I major histocompatibility antigens (HLA) have been identified as substrates for protein kinase C in vitro. IL-2 receptors on normal human T lymphocytes and the leukemic cell line, HUT102B2, are rapidly phosphorylated in vivo in response to the tumor-promoting phorbol ester, 12-O-tetradecanoylphorbol 13-acetate (TPA). Tryptic peptide analysis showed that the in vitro and in vivo 32P-labeled IL-2 receptors were phosphorylated on the same sites. A synthetic peptide corresponding to the carboxyl-terminal cytoplasmic tail of the IL-2 receptor was shown to be phosphorylated in vitro by protein kinase C. Tryptic digestion of the peptide generated the same 32P-labeled species as those found for the IL-2 receptor. From these studies, it was concluded that Ser-247 is the major site of phosphorylation in the IL-2 receptor and that Thr-250 is a minor site. These results also provide direct evidence that the in vivo phosphorylation of the IL-2 receptor stimulated by TPA is catalyzed by protein kinase C. The sites phosphorylated in the HLA antigens in vitro by protein kinase C or in vivo after TPA stimulation were also localized to the carboxyl-terminal cytoplasmic domain of the heavy chain by limited proteolysis.
白细胞介素-2(IL-2)受体、白细胞特异性膜糖蛋白T200以及I类主要组织相容性抗原(HLA)在体外已被确定为蛋白激酶C的底物。正常人T淋巴细胞和白血病细胞系HUT102B2上的IL-2受体,在体内会因促肿瘤佛波酯12-O-十四酰佛波醇13-乙酸酯(TPA)而迅速磷酸化。胰蛋白酶肽段分析表明,体外和体内经32P标记的IL-2受体在相同位点被磷酸化。一段与IL-2受体羧基末端胞质尾相对应的合成肽,在体外被蛋白激酶C磷酸化。该肽经胰蛋白酶消化产生的32P标记产物与IL-2受体的相同。从这些研究得出结论,Ser-247是IL-2受体磷酸化的主要位点,而Thr-250是次要位点。这些结果还提供了直接证据,表明TPA刺激的IL-2受体在体内的磷酸化是由蛋白激酶C催化的。经蛋白激酶C体外磷酸化或TPA刺激后体内磷酸化的HLA抗原中的磷酸化位点,也通过有限蛋白酶解定位到重链的羧基末端胞质结构域。